SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
GKOS

GLAUKOS Corp (New York Stock Exchange:GKOS)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
178.89+0.01 (+0.01%)
 
Market cap
$10.6B
Analyst consensus
Listed since
Jun 25, 2015
Insider Score
––Not scored
GKOS Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

GKOS Stock Insider Trading Activity

GKOS stock’s insider trading shows 22 sales on the open market for an estimated $18.18M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Navratil Tomas
Other
Sell888$163.93$145.57K 1.3%69,930Oct 5, 2026— Form 4
Navratil Tomas
Other
Sell312$165.60$51.67K 0.4%69,291Oct 5, 2026— Form 4
Navratil Tomas
Other
Sell327$164.78$53.88K 0.5%69,603Oct 5, 2026— Form 4
Navratil Tomas
Other
Sell136$152.71$20.77K 0.2%72,130Sep 25, 2026— Form 4
Navratil Tomas
Other
Sell1,083$154.88$167.74K 1.5%70,818Sep 25, 2026— Form 4
Navratil Tomas
Other
Sell229$154.24$35.32K 0.3%71,901Sep 25, 2026— Form 4
Navratil Tomas
Other
Sell167$151.70$25.33K 0.2%72,266Sep 25, 2026— Form 4
Navratil Tomas
Other
Sell103$163.20$16.81K 0.1%73,787Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell4$172.00$688 0.0%72,433Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell234$170.95$40.00K 0.3%72,437Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell120$168.38$20.21K 0.2%72,671Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell460$167.32$76.97K 0.6%72,791Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell191$166.20$31.74K 0.3%73,251Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell345$164.60$56.79K 0.5%73,442Sep 16, 2026— Form 4
Navratil Tomas
Other
Sell10$182.50$1.82K 0.0%73,890Aug 28, 2026— Form 4
Navratil Tomas
Other
Sell7,643$180.25$1.38M 8.7%79,991Aug 28, 2026— Form 4
Navratil Tomas
Other
Sell6,091$181.19$1.10M 7.6%73,900Aug 28, 2026— Form 4
Kliman Gilbert H
Director
Sell2,500$190.00$475.00K 6.3%37,406Aug 19, 2026— Form 4
Kliman Gilbert H
Director
Option exercise2,500$25.77$64.42K 6.7%39,906Aug 19, 2026— Form 4
Gilliam Joseph E
COO
Option exercise10,000$48.46$484.60K 8.2%132,588Aug 11, 2026— Form 4
Gilliam Joseph E
COO
Option exercise20,000$55.18$1.10M 19.5%122,588Aug 11, 2026— Form 4
Gilliam Joseph E
COO
Option exercise20,000$55.18$1.10M 24.2%102,588Aug 11, 2026— Form 4
Gilliam Joseph E
COO
Option exercise10,000$48.46$484.60K 13.8%82,588Aug 11, 2026— Form 4
Gilliam Joseph E
COO
Sell32,037$180.49$5.78M 30.6%72,588Aug 11, 2026— Form 4
Gilliam Joseph E
COO
Sell27,963$178.89$5.00M 21.1%104,625Aug 11, 2026— Form 4
Thurman Alex R.
CFO
Sell20,000$180.13$3.60M 31.3%43,906Aug 7, 2026— Form 4
Thurman Alex R.
CFO
Option exercise20,000$33.81$676.20K 45.6%63,906Aug 7, 2026— Form 4
WEN LEANA
Director
Sell525$167.63$88.01K 2.4%21,092Jul 31, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.